Here is the latest financial fact sheet of SANDU PHARMA. For more details, see the SANDU PHARMA quarterly results and SANDU PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -2.1 |
No. of shares | m | 9.66 |
1 Week | % | -2.0 |
1 Month | % | 5.3 |
1 Year | % | 7.9 |
52 week H/L | Rs | 85.0/49.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SANDU PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 40 | 27 | 44 | 76 | 86 | |
Low | Rs | 18 | 10 | 12 | 29 | 50 | |
Sales per share (Unadj.) | Rs | 69.8 | 68.4 | 74.2 | 74.3 | 67.6 | |
Earnings per share (Unadj.) | Rs | 0.9 | 1.0 | 1.4 | 1.8 | 1.6 | |
Diluted earnings per share | Rs | 0.7 | 0.7 | 1.1 | 1.6 | 1.6 | |
Cash flow per share (Unadj.) | Rs | 1.8 | 1.8 | 2.1 | 2.4 | 2.1 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0.50 | 0.75 | 0.75 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.41 | 0.68 | 0.75 | |
Avg Dividend yield | % | 0 | 0 | 1.8 | 1.4 | 1.1 | |
Book value per share (Unadj.) | Rs | 40.7 | 41.3 | 41.2 | 40.9 | 40.6 | |
Adj. book value per share | Rs | 29.8 | 30.3 | 33.7 | 37.3 | 40.6 | |
Shares outstanding (eoy) | m | 7.08 | 7.08 | 7.92 | 8.81 | 9.66 | |
Price / Sales ratio | x | 0.4 | 0.3 | 0.4 | 0.7 | 1.0 | |
Avg P/E ratio | x | 30.9 | 18.4 | 20.0 | 29.1 | 43.3 | |
P/CF ratio (eoy) | x | 15.9 | 10.4 | 13.3 | 21.8 | 32.3 | |
Price / Book Value ratio | x | 0.7 | 0.5 | 0.7 | 1.3 | 1.7 | |
Dividend payout | % | 0 | 0 | 36.2 | 41.6 | 47.6 | |
Avg Mkt Cap | Rs m | 207 | 133 | 219 | 463 | 658 | |
Total wages/salary | Rs m | 65 | 69 | 80 | 89 | 111 |
SANDU PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 494 | 484 | 588 | 655 | 653 | |
Other income | Rs m | 6 | 4 | 2 | 1 | 3 | |
Total revenues | Rs m | 500 | 488 | 589 | 656 | 657 | |
Gross profit | Rs m | 21 | 15 | 22 | 29 | 25 | |
Depreciation | Rs m | 6 | 6 | 6 | 5 | 5 | |
Interest | Rs m | 10 | 4 | 1 | 1 | 1 | |
Profit before tax | Rs m | 10 | 9 | 17 | 23 | 22 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 3 | 2 | 6 | 7 | 7 | |
Profit after tax | Rs m | 7 | 7 | 11 | 16 | 15 | |
Gross profit margin | % | 4.2 | 3.2 | 3.7 | 4.4 | 3.8 | |
Effective tax rate | % | 34.2 | 21.6 | 35.0 | 31.4 | 31.4 | |
Net profit margin | % | 1.4 | 1.5 | 1.9 | 2.4 | 2.3 |
SANDU PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 201 | 224 | 305 | 236 | 255 | |
Current liabilities | Rs m | 139 | 113 | 125 | 119 | 139 | |
Net working cap to sales | % | 12.6 | 22.9 | 30.7 | 18.0 | 17.8 | |
Current ratio | x | 1.4 | 2.0 | 2.4 | 2.0 | 1.8 | |
Inventory Days | Days | 48 | 18 | 2 | 51 | 65 | |
Debtors Days | Days | 35,414,145 | 35,269,399 | 332 | 222 | 268 | |
Net fixed assets | Rs m | 236 | 190 | 164 | 256 | 286 | |
Share capital | Rs m | 71 | 71 | 79 | 88 | 97 | |
"Free" reserves | Rs m | 217 | 222 | 247 | 272 | 296 | |
Net worth | Rs m | 288 | 292 | 326 | 360 | 392 | |
Long term debt | Rs m | 2 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 436 | 414 | 470 | 493 | 542 | |
Interest coverage | x | 2.0 | 3.1 | 15.6 | 22.1 | 28.7 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.1 | 1.2 | 1.3 | 1.3 | 1.2 | |
Return on assets | % | 3.9 | 2.8 | 2.6 | 3.4 | 3.0 | |
Return on equity | % | 2.3 | 2.5 | 3.4 | 4.4 | 3.9 | |
Return on capital | % | 7.0 | 4.6 | 5.5 | 6.7 | 5.9 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
SANDU PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 37 | 62 | 76 | 9 | 2 | |
From Investments | Rs m | -1 | -4 | -56 | -55 | 5 | |
From Financial Activity | Rs m | -43 | -54 | 13 | 9 | 6 | |
Net Cashflow | Rs m | -6 | 5 | 33 | -36 | 13 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Balram Viswanathan | COMP SEC: Pratika Mhambray | YEAR OF INC: 1985 | BSE CODE: 524703 | FV (Rs): 10 | DIV YIELD (%): 1.2 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare SANDU PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.